{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:03:32Z","timestamp":1773288212719,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2011,1,23]],"date-time":"2011-01-23T00:00:00Z","timestamp":1295740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Multiprotein complex formation with p210<jats:sup>BCR\u2010ABL1<\/jats:sup> is likely to play a major role in determining cellular abnormalities in chronic myeloid leukaemia (CML). Although many p210<jats:sup>BCR\u2010ABL1<\/jats:sup> binding partners have been identified, it is likely that many have not. We evaluated the use of co\u2010immunoprecipitation and antibody arrays and found that this approach is capable of identifying new p210<jats:sup>BCR\u2010ABL1<\/jats:sup> binding partners, and may contribute to the search for new therapeutic targets in CML.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2010.08450.x","type":"journal-article","created":{"date-parts":[[2011,1,24]],"date-time":"2011-01-24T05:04:53Z","timestamp":1295845493000},"page":"611-614","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Antibody arrays identify protein\u2010protein interactions in chronic myeloid leukaemia"],"prefix":"10.1111","volume":"152","author":[{"given":"Hetal","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Nteliopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zacharoula","family":"Nikolakopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrtle Y.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,23]]},"reference":[{"issue":"8","key":"e_1_2_5_2_1","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1242\/jcs.113.8.1319","article-title":"The p120 catenin family: complex roles in adhesion, signaling and cancer","volume":"113","author":"Anastasiadis P.Z.","year":"2000","journal-title":"Journal of Cell Science"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2004.04.001"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0900653106"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2008.05.004"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2008.06.002"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428190903147637"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-005-0705-x"},{"key":"e_1_2_5_9_1","first-page":"358","article-title":"Databases of protein\u2010protein interactions and their use in drug discovery","volume":"12","author":"Fuentes G.","year":"2009","journal-title":"Current Opinion in Drug Discovery and Development"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007439"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1042\/CS20040336"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.10.004"},{"key":"e_1_2_5_13_1","first-page":"1799","article-title":"Geldanamycin and its analogue 17\u2010allylamino\u201017\u2010demethoxygeldanamycin lowers Bcr\u2010Abl levels and induces apoptosis and differentiation of Bcr\u2010Abl\u2010positive human leukemic blasts","volume":"61","author":"Nimmanapalli R.","year":"2001","journal-title":"Cancer Research"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20377"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2405057"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0190"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2010.08450.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2010.08450.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T13:20:41Z","timestamp":1697376041000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2010.08450.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,23]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1111\/j.1365-2141.2010.08450.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08450.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,23]]},"assertion":[{"value":"2011-01-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}